Pegavision Corporation (TPE:6491)

Taiwan · Delayed Price · Currency is TWD

373.00

-6.00 (-1.58%)

Aug 7, 2026, 1:30 PM CST

18.60% (1Y)

Market Cap	28.65B +16.8%
Revenue (ttm)	7.82B +17.2%
Net Income	1.84B +11.7%
EPS	23.42 +12.0%
Shares Out	76.80M
PE Ratio	15.93
Forward PE	13.89
Dividend	10.00 (2.64%)
Ex-Dividend Date	Aug 7, 2026

Volume	750,208
Open	369.50
Previous Close	379.00
Day's Range	369.50 - 379.50
52-Week Range	270.50 - 390.00
Beta	0.77
Analysts	Buy
Price Target	400.57 (+7.39%)
Earnings Date	Aug 12, 2026

About Pegavision

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2009

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6491

Full Company Profile

Financial Performance

In 2025, Pegavision's revenue was 7.04 billion, an increase of 3.26% compared to the previous year's 6.82 billion. Earnings were 1.63 billion, a decrease of -11.07%.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 6491 stock is "Buy." The 12-month stock price target is $400.57, which is an increase of 7.39% from the latest price.

Price Target

$400.57

(7.39% upside)

Analyst Consensus: Buy

Stock Forecasts